An invention relates to methyl-and trifluoro¬methyl-substituted pyrrolopyridines, of formula (I), (I) pharmaceutical compositions thereof, methods of modulating RORγ activity and/or reducing amount of IL-17 in a subject, and usage of pyrrolopyridines and pharmaceutical compositions thereof at the treatment of various medical disorders.